Elsevier LogoCOVID-19

    ThisiscontentfromClinicalKey

    Acute ethanol toxicity

    Sign up for your free ClinicalKey trial today!  Your first step in getting the right answers when you need them.

    Start Free Trial
    Nov.20.2024

    Acute Ethanol Toxicity

    Synopsis

    Key Points

    • Acute ethanol toxicity results from ingesting ethanol faster than it can be metabolized by the liver and eliminated, leading to accumulation of ethanol and its metabolites in the blood
    • Ethanol intoxication presents with variable manifestations progressing from mild (eg, altered sensorium, ataxia, incoordination, nystagmus) to severe (eg, stupor, respiratory depression, coma) with increasing blood ethanol concentrations
    • Children are at particularly high risk for adverse effects of ethanol (eg, hypoglycemia, hypothermia, coma) despite relatively small amount of ethanol ingested
    • Acute toxicity is diagnosed by clinical presentation and DSM-5 criteria
    • Ancillary studies may be required depending on individual presentation (eg, glucose, electrolytes, blood or breath ethanol levels)
    • Additional considerations at time of presentation include exclusion of occult trauma and alternative diagnosis
    • Treatment largely involves symptomatic care; no antidote is available for ethanol intoxication; replace thiamine when indicated r1
    • Conditions associated with acute ethanol toxicity that may require treatment include hypoglycemia, dehydration, vomiting, electrolyte abnormalities (eg, hyponatremia, hypomagnesemia), seizures, and agitation
    • Potential complications are numerous and include aspiration, gastritis, pancreatitis, cardiac arrhythmias, increased risk of suicide and violent crime, and death
    • General prognosis of uncomplicated acute ethanol toxicity is favorable with appropriate supportive care

    Urgent Action

    • Standard airway protection and respiratory support may be required for obtunded patients or patients with respiratory depression
    • Treat hypotension secondary to volume depletion and dehydration in standard fashion beginning with isotonic IV fluid bolus
    • Hypoglycemia requires immediate correction with dextrose bolus followed by infusion and frequent monitoring
    • Seizures are often caused by hypoglycemia; correct hypoglycemia and treat continued seizure activity in standard fashion; seizure activity without hypoglycemia suggests presence of intracranial pathology (eg, hemorrhage) or significant electrolyte abnormality (eg, hyponatremia)
    • Hypothermia requires immediate external warming measures (eg, warm blankets, external warming system)
    • First line treatment for significant agitation and aggression is a typical antipsychotic (eg, haloperidol)

    Pitfalls

    • Diagnosis of acute ethanol intoxication may lead some clinicians to disregard search for additional severe disease and occult injury
      • Evaluate and monitor for occult trauma, potential alcohol-related disease, and non–alcohol-related conditions in patients diagnosed with acute ethanol intoxication r2
      • Avoid temptation to rapidly discharge unruly patients and to minimize issues in pleasantly intoxicated patients r3
    • Young children are prone to significant hypoglycemia and other serious effects (eg, coma, hypothermia) with exposure to relatively small amounts of ethanol
      • Maintain care to aggressively monitor for and treat life-threatening ethanol-related effects in young children
    • Maintain awareness of limitations of blood ethanol concentration measurement; the concentration values do not necessarily correlate with clinical presentation, they lack predictive ability regarding clinical severity and outcome, and they often do not affect treatment decisions

    Terminology

    Clinical Clarification

    • Acute ethanol toxicity results from ingesting ethanol faster than it can be metabolized by the liver and eliminated, leading to accumulation of ethanol and its metabolites in the blood
      • Result is intoxication with variable manifestations ranging from mild (eg, altered sensorium, ataxia, incoordination) to severe (eg, stupor, respiratory depression, coma) with increasing blood ethanol concentrations

    Classification

    • DSM-5 diagnostic criteria r4
      • Recent ingestion of ethanol
      • Clinically significant problematic behavior or psychological changes (eg, inappropriate sexual or aggressive behavior, mood lability, impaired judgment) that developed during, or shortly after, ethanol ingestion
      • One (or more) of the following signs or symptoms developing during, or shortly after, ethanol use
        • Slurred speech
        • Incoordination
        • Unsteady gait
        • Nystagmus
        • Impaired attention or memory
        • Stupor or coma
      • Signs and symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance

    Diagnosis

    Clinical Presentation

    History

    • Common presenting patterns r5
      • Traumatic injuries related to intoxication c1
        • Commonly related to motor vehicle accidents, nonfatal drowning, and violence c2c3c4
      • Medical complications related to intoxication
        • May include atrial fibrillation, pancreatitis, Mallory-Weiss tear, acute alcoholic hepatitis, dehydration, and electrolyte abnormalities c5c6c7c8c9c10
      • Intoxication alone
        • Accidental ingestion may occur in children c11
          • Ethanol-containing household products (eg, mouthwash, hand sanitizers, perfumes) account for most exposures c12c13c14
          • Unattended ethanol-containing beverages and medications (eg, cough and cold preparations) account for some exposures c15c16
        • Forced or coerced ingestion may occur in association with child sexual abuse or adolescent sexual assault c17c18c19
        • Cognitive impairment and dementia may be worsened by ingestion in elderly c20c21
    • Symptoms are dose-dependent and are more pronounced when ethanol concentrations are increasing than when they are declining r6
      • 1 to 2 standard drinks: mild euphoria, increased talkativeness, loosened inhibition, impaired judgment, relaxation, feeling of well-being, slowed motor performance, and impairment in some tasks requiring skill c22c23c24c25c26c27c28
      • 3 to 5 standard drinks: incoordination c29
      • 6 to 10 standard drinks: mood lability and overexpression (eg, sadness, anger), personality and behavioral changes, impaired cognition and memory, impaired judgment, altered perception of environment, slurred speech, marked incoordination, and ataxia c30c31c32c33c34c35c36c37c38c39
      • More than 10 standard drinks: nausea and vomiting (from pyloric spasm), marked slurring of speech, diplopia, and blackouts (amnesia) c40c41c42
        • Many more than 10 standard drinks: hypoventilation, coma, respiratory arrest c43c44c45
    • Individual variability exists in the dose necessary to produce various symptoms
      • Patients with ethanol tolerance may manifest few symptoms despite relatively high blood ethanol concentration; in contrast, ethanol-naive patients may manifest symptoms at lower blood ethanol concentrations (eg, coma in young child or teen with concentration of 100-200 mg/dL) r7
      • Constellation of possible symptoms of intoxication varies among individual patients r8
    • Pattern and characteristics of mental status changes are often similar in a given person from one intoxication episode to another
      • Markedly uncharacteristic mental status changes from previous episodes of intoxication may indicate additional pathology (eg, occult head injury, electrolyte abnormality, concomitant use of additional illicit drugs)
    • Many patients seeking care for acute ethanol intoxication present with concomitant medical problems related to excessive long-term ethanol use or alcohol use disorder d1
      • Denial or minimization of intake and maladaptive ethanol use patterns are common; close contacts (eg, significant other, roommate) may provide more accurate account of ethanol use c46
      • Patients also often deny or minimize impaired motor and cognitive functions during intoxication c47c48
    • Coingestion of another drug, or several drugs, is not uncommon in intoxicated patients presenting for emergent care r2c49

    Physical examination

    • Signs of acute mild to moderate intoxication
      • Ethanol smell on breath c50
      • Conjunctival injection c51
      • Slurred speech, incoordination, ataxia, and nystagmus c52c53c54
      • Hyperreflexia c55
      • Impaired sensation c56
      • Impaired attention c57
      • Impaired memory c58
        • Temporary anterograde amnesia (blackout) results from a rapid increase in blood ethanol concentration r6c59
        • Patient may not recall any events that happened during intoxication (en bloc amnesia) or may recall only parts of the episode (fragmentary amnesia) r6c60c61
      • Tachycardia c62
      • Signs of volume depletion (eg, tacky or dry mucous membranes, lack of tears, prolonged capillary refill time) c63c64c65c66
      • Significant skill deficits (eg, inability to walk, talk, or drive), but preserved consciousness c67c68c69c70
    • Signs of severe intoxication
      • Impairment or absence of gag reflex c71c72
      • Hypoventilation c73
      • Hypothermia c74
      • Hypotension secondary to peripheral vasodilation and/or volume depletion c75
      • Respiratory depression and arrest c76c77
      • Stupor or coma c78c79
      • Abnormal eye movements r9c80
        • Increased fixation
        • Saccades c81
    • Seizure activity c82
      • Usually a consequence of ethanol-related hypoglycemia; common adrenergic symptoms associated with hypoglycemia are often absent (eg, diaphoresis)r7c83
    • Less prevalent manifestations that may occur during episode of heavy drinking
      • Abnormal heart rhythms (eg, atrial fibrillation, ventricular rhythms); these may occur in patients without other evidence of heart disease or in patients with underlying cardiac pathology c84c85c86
    • Signs suggestive of long-term ethanol use
      • Prominent capillaries (eg, nose, cheeks) c87
      • Spider nevi c88
      • Telangiectasias c89
      • Palmar erythema c90
      • Hepatomegaly from fatty liver, alcoholic hepatitis, or hepatic cirrhosis c91d2
      • Hypertension c92
      • Findings consistent with cardiomyopathy (eg, left ventricular heart failure with mitral regurgitation) c93c94
  • Manifestations of alcohol intoxication based on blood ethanol concentration.Standard drink contains about 10 to 14 g of ethanol (depending on exact ethanol percentage in each beverage/product); expected increase in blood ethanol concentration after 1 standard drink is about 15 to 25 mg/dL in a 70-kg man.Data from Jung YC et al: Alcohol: intoxication and poisoning--diagnosis and treatment. Handb Clin Neurol. 125:115-21, 2014; Vonghia L et al: Acute alcohol intoxication. Eur J Intern Med. 19(8):561-7, 2008; Vale A: Alcohols and glycols. Medicine. 44(3):128-32, 2016; and Department of Health and Human Services: Appendix 9: alcohol. In: Dietary Guidelines for Americans, 2015-2020. HHS website. Updated 2015. Accessed March 1, 2019. https://health.gov/dietaryguidelines/2015/guidelines/appendix-9/
    Blood alcohol concentrationApproximate alcohol consumptionManifestations
    Less than 50 mg/dL1 to 2 standard drinksMild euphoria, increased talkativeness, relaxation, feeling of well-being, loosened inhibition, impaired judgment, slowed motor performance, impairment in some tasks requiring skill
    More than 50 mg/dL3 to 5 standard drinksImpaired sensation, incoordination
    More than 100 mg/dL6 to 10 standard drinksMood lability, personality and behavioral changes, impaired cognition and memory, impaired judgment, altered perception of environment, prolonged reaction time, slurred speech, hyperreflexia, marked incoordination, ataxia, mild nystagmus
    More than 200 mg/dLMore than 10 standard drinksNausea, vomiting, marked nystagmus, diplopia, alcoholic blackouts (amnesia), marked slurring of speech, increased risk of aspiration
    More than 300 mg/dLHypoventilation, diminishing ability to protect and maintain airway, hypothermia, cardiac arrhythmia
    More than 400 mg/dLComa, absent gag reflex, respiratory arrest, hypotension, death

    • Causes and Risk Factors

    Causes

    • Pharmacology
      • Ethanol (ethyl alcohol) is a central nervous system depressant (interferes with cortical functioning in small doses and medullary functioning in high doses) and a peripheral vasodilator r7c95
      • Common ethanol-containing substances
        • Ethanol-containing beverages
          • Standard drink contains about 10 to 14 g of ethanol (about 0.4-0.6 fl oz), depending on exact ethanol percentage in each beverage/product; expected increase in blood ethanol concentration after 1 standard drink is about 15 to 25 mg/dL in a 70-kg man r3r6r7
          • One standard drink usually equates to about 1.5 oz of 80 proof liquor (40% ethanol), 5 oz of wine (12% ethanol), or 12 oz of beer (5% ethanol) r10
        • Powdered ethanol (eg, Palcohol)
          • Palcohol when mixed with 200 mL of water results in 55% ethanol by volume (10% ethanol by weight) r2
            • Many US states have adopted legislation banning sale of such products r11
        • Medication preparations
          • Cough and allergy remedies may contain up to 16% ethanol r2
          • Cough remedies may contain up to 25% ethanol r2
        • Food extracts
          • Vanilla extract contains no less than 35% ethanol by US law r12
        • Household products
          • Glass cleaners may contain up to 10% ethanol r2
          • Hand sanitizer may contain up to 62% ethanol r2
        • Cosmetics and personal care items
          • Mouthwash may contain up to 25% ethanol r2
          • Perfumes and colognes may contain up to 95% ethanol r2
          • Aftershave products may contain up to 80% ethanol r2
      • Factors affecting extent of intoxication r2r6
        • Volume ingested, ethanol concentration of the ingested liquid, and time course of ingestion
        • State of fasting
          • Fasting results in increased blood ethanol concentration
          • Food in stomach delays absorption, resulting in lower blood ethanol concentration and delayed peak concentration
        • Sex: gastric alcohol dehydrogenase metabolism is lesser in females, resulting in increased absorption and blood ethanol concentrations
        • Individual body weight and composition: increased adiposity and decreased lean body weight result in higher blood ethanol concentrations
        • Long-term ethanol use
          • Heavy drinkers with significant tolerance manifest fewer signs and symptoms of intoxication at any given blood ethanol concentration
          • Patients with severe liver disease may have decreased rates of ethanol metabolism that correlate with severity of hepatic damage
        • Genetic susceptibility may play a role in differences in individual manifestations of intoxication
        • Medications and coingestion of additional substances may have variable effects on blood ethanol concentration (ie, either augment effects or antagonize effects)
      • Absorption
        • Most ingested ethanol is absorbed in small intestine;r7 stomach absorbs about 10% r6
        • Absorption is rapid; peak serum levels are usually achieved between 30 and 90 minutes r6
      • Metabolism
        • Substantial variability exists in rates of ethanol degradation among individual patients; consumption of ethanol exceeding rate of degradation and elimination results in accumulation and manifestations of intoxication r8
          • In general, patients can metabolize 1 standard drink per hour without ethanol accumulation in blood and resultant intoxication
          • People without heavy long-term ethanol use (ie, those who are nontolerant or ethanol-naive) metabolize and eliminate ethanol at a rate of about 15 mg/dL/hour r8
          • People with heavy long-term ethanol use metabolize and eliminate ethanol faster, at rates up to 25 mg/dL/hour r8
        • Ethanol metabolism involves 2 enzymes: alcohol dehydrogenase (converts ethanol to acetaldehyde) and aldehyde dehydrogenase (converts acetaldehyde to acetic acid)
        • Gastric alcohol dehydrogenase is responsible for about 10% of metabolism before absorption (ie, first-pass metabolism) r3
          • Young women have lower gastric alcohol dehydrogenase activity r7
        • Liver enzymatic pathways account for remaining 90% of metabolism r3
          • Liver alcohol dehydrogenase contributes to most hepatic metabolism (about 90%) r3
            • Diminished activity of alcohol dehydrogenase in young children may be responsible for decreased ability to metabolize ethanol, resulting in rapid increase in blood ethanol concentration and toxicity r13
          • Microsomal ethanol-oxidizing system, another hepatic enzyme system, accounts for a minority of hepatic metabolism (about 8%-10%) r3
            • Activity of this enzyme system can be induced by long-term ethanol use and enzyme-inducing drugs r7
          • Catalase is a very minor contributor to hepatic metabolism (about 0%-2%) r3
      • Elimination
        • Most ingested ethanol is metabolized to acetaldehyde and acetate, eventually resulting in carbon dioxide and water; remainder is excreted unchanged in the urine and (to a lesser extent) in the breath and through the skin r7
    • Toxic dose
      • Toxic dose variesr14r10 but has been defined as 5 g/kg in an adult and 3 g/kg in a childr2
      • Symptoms are usually related to blood ethanol concentration
        • Increased risk of respiratory depression and arrest may occur with concentrations exceeding 300 mg/dL r3
        • Lethal dose varies
          • Death attributable to acute intoxication generally occurs with concentrations exceeding 500 mg/dL r3
          • Death attributable to acute intoxication in nontolerant or ethanol-naive patients may occur at lower concentrations (eg, 300-500 mg/dL) r3
          • Fatal complications may occur at much lower blood ethanol concentrations in children (less than 50 mg/dL) r2

    Risk factors and/or associations

    Age
    • Children and elderly people are at highest risk of intoxicating effects of ethanol compared with other age groups r2c96c97c98c99
    • Children may be at increased risk for profound effects (eg, hypoglycemia, hypothermia, coma) after ingesting relatively small amounts of ethanol r15
    Other risk factors/associations
    • Risk factors for development of hypoglycemia associated with acute intoxication

    Diagnostic Procedures

    Primary diagnostic tools

    • Intoxication is diagnosed by clinical presentation and DSM-5 criteria c104c105
    • Obtain the following ancillary tests at presentation:
      • Bedside glucose measurement in all intoxicated patients, all exposed children, and patients with mental status depression r8c106
      • Electrolyte levels in patients with moderate to severe intoxication and in patients requiring IV fluid hydration r16c107
      • Assessment of blood ethanol concentration (either directly or indirectly) is commonly performed in patients with moderate to severe manifestations, in children,r5 and in patients with mental status depression and unknown history of ethanol exposurer2
        • Direct blood ethanol concentration measurement c108c109
          • May confirm diagnosis of ethanol exposure and deem alternative alcohol exposure less likely (eg, exposure to ethylene glycol, methanol, or isopropyl alcohol); however, coingestion of other alcohols can occur r6
          • Obtain in patients for whom legal ramifications are evident (eg, concern for child abuse, adult operating machinery or vehicle) r6
        • Breath analysis c110
          • Less invasive but less accurate than blood ethanol concentration measurement
        • Serum osmolality and osmolal gap c111c112
          • May be used as an indirect measure of blood ethanol concentration when direct measurement is unavailable
      • Assessment of acid-base status in severely intoxicated patients (eg, those with hypothermia, in shock, or in coma) r7c113
    • Remember to evaluate for potential alcohol-related disease and non–alcohol-related conditions in patients with suspected or diagnosed acute ethanol intoxication r3
      • Exclude occult trauma as needed
        • Order head CT when neurologic signs are present, head trauma is suspected, and/or mental status is not improving as anticipated r6c114
        • Maintain low threshold for cervical spine imaging; intoxicated patients are not candidates for clearing of cervical spine clinically
      • Consider possibility of coingestion, based on history and examination
      • Additional studies may be indicated to exclude alternative diagnosis, depending on individual presentation, such as the following:
        • Other substance-related mental status depression (eg, naloxone trial for possible opioid toxicity) c115
        • Central nervous system infections such as encephalitis and meningitis (eg, cerebrospinal fluid analysis) c116
        • Encephalopathic states (eg, liver function testing) c117
      • Other studies that may be indicated based on clinical presentation
        • Chest radiograph to assess for aspiration in patients with respiratory symptoms or vomiting plus mental status depression c118
        • Sexual assault or abuse evaluation if concerns exist
    • Incidental findings consistent with excessive long-term ethanol use r6d1
      • Elevated mean corpuscular volume, γ-glutamyltransferase level, and carbohydrate-deficient transferrin level
      • Anemia, neutropenia, and thrombocytopenia
    • Obtain routine tests after intentional ingestion with intent for self-harm
      • Serum acetaminophen concentration
      • Urine/serum hCG level in women of childbearing age c119
      • Head CT with any significant unexpected alteration in sensorium, prolonged or focal seizures, signs of increased intracranial pressure, or focal neurologic deficit

    Laboratory

    • Measurement or estimation of blood ethanol concentration c120
      • Limitations
        • Values do not necessarily correlate with clinical presentation r6
        • Values lack predictive ability regarding clinical severity and outcome r6
        • Values often do not influence decisions on management or disposition r2
      • Most common tests
        • Blood ethanol concentration (direct measurement)
          • Legal intoxication level above which penalties may be imposed for operating a vehicle or machinery in most states in the United States is 80 mg/dL (or 0.08 g/dL) r6
          • Absence of significant manifestations (eg, motor impairment, cognitive impairment) with concentration more than 100 mg/dL suggests tolerance and long-term ethanol use r6
          • Severe intoxication manifestations are usually associated with concentrations more than 300 mg/dL r7
        • Indirect/proxy measurements
          • Breath ethanol concentration c121
            • Analysis is less reliable than blood concentration analysis; results are often slightly lower than blood concentration r2r6
            • Testing within 15 to 20 minutes of last drink and with presence of vomitus in mouth may cause false elevation; false-negatives are rare r2
          • Serum osmolality and osmolal gap
            • Serum osmolality c122
              • Measure of total molal concentration of all osmotically active solutes in plasma r17
              • General reference range for serum osmolality is 285 to 290 mOsm/L r18
              • Abnormally high measured serum osmolality not explained by increased level of urea, glucose, or sodium indicates accumulation of low-molecular-weight osmotically active substances in plasma r18
              • Serum osmolality rises about 22 mOsm/L for every 100 mg/dL increment in blood ethanol concentration r3
            • Osmolal gap c123
              • Screening test for presence of unmeasured, osmotically active substances in serum r17
              • Osmolal gap = measured serum osmolality − calculated osmolality
              • When ethanol concentration is not available, calculated osmolality = (2 × Na) + (BUN/2.8) + (glucose/18)
              • Reference range for osmolal gap can vary, but generally, values more than 10 mOsm/L are considered elevated r19
              • Causes of an elevated osmolal gap can include alcohols (eg, ethanol, ethylene glycol, methanol, isopropanol, propylene glycol), glycerol, mannitol, acetone, sorbitol, ketoacidosis, and unknown osmotically active solutes in critical illness (eg, multiorgan failure, renal failure, circulatory shock) r20r21
              • Serum osmolal gap out of proportion to blood ethanol concentration suggests presence of additional unmeasured osmotically active substance (eg, coingestion of ethanol plus another alcohol)
    • Blood glucose level c124
      • Disturbance typically occurs within 6 to 36 hours of ingestion r7
      • Hypoglycemia is most common in children and adolescents, particularly children younger than 5 years r5r7
        • Development of hypoglycemia in children does not appear to be dose dependent r2
        • Children can develop hypoglycemia with blood ethanol concentrations less than 30 mg/dL r2
      • Other risk factors for development of hypoglycemia include vigorous exercise, fasting state, and chronic malnutrition r7
    • Serum electrolyte levels c125
      • Abnormalities may include hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia r3r5
    • Acid-base disorders r7c126
      • May occur with severe intoxication
      • Respiratory acidosis is more common than metabolic acidosis
      • Metabolic alkalosis may develop with persistent vomiting and dehydration

    Imaging

    • Head CT c127
      • Clinically important signs of trauma may include evidence of skull fracture, subdural hematoma, epidural hematoma, and subarachnoid bleeding
      • Incidental findings consistent with long-term ethanol use include brain atrophy with ventricular enlargement and widened cortical sulci most pronounced in prefrontal cortex r6

    Other diagnostic tools

    • DSM-5 diagnostic criteria for alcohol (ethanol) intoxication r4
      • Recent ingestion of alcohol (ethanol)
      • Clinically significant problematic behavior or psychological changes (eg, inappropriate sexual or aggressive behavior, mood lability, impaired judgment) that developed during, or shortly after, alcohol (ethanol) ingestion
      • One (or more) of the following signs or symptoms developing during, or shortly after, alcohol (ethanol) use:
        • Slurred speech
        • Incoordination
        • Unsteady gait
        • Nystagmus
        • Impairment in attention or memory
        • Stupor or coma
      • Signs and symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance

    Differential Diagnosis

    Most common

    • Ethylene glycol toxicity r17r22c128d3
      • Results from ingestion of products containing ethylene glycol (eg, antifreeze, brake fluid, radiator coolant, deicing solution)
      • Presentation is often similar, with signs of altered mental status, nystagmus, ataxia, slurred speech, euphoria, vomiting, and increased osmolal gap
      • Ethylene glycol is odorless; patients presenting with acute ethanol ingestion usually present with distinct breath odor
      • Severe metabolic acidosis with increased anion gap suggests ethylene glycol ingestion rather than isolated ethanol ingestion; ethanol may cause mild-moderate acidosis, but a severe increased anion gap metabolic acidosis is not typical
      • Crystalluria and hypocalcemia commonly develop over time in patients with ethylene glycol toxicity; renal failure may result and suggests ethylene glycol ingestion rather than isolated ethanol ingestion
      • Diagnosis is typically based on a high index of suspicion with proper interpretation of adjunct laboratory diagnostics (eg, presentation consistent with alcohol intoxication, increased osmolal gap, severe increased anion gap metabolic acidosis, crystalluria, hypocalcemia, absence of detectable serum ethanol concentration) and improvement with proper treatment (eg, antidote fomepizole)
      • Serum ethylene glycol concentration confirms diagnosis but is of limited use given need for reference laboratory testing (lengthy turnaround time)
    • Methanol toxicity r17r23c129
      • Results from ingestion of methanol-containing products (eg, denatured alcohol, automotive fluids, embalming fluids, paints, varnishes, wood stains, lacquer, paint thinner)
      • Presentation is often similar with signs of altered mental status, nystagmus, ataxia, slurred speech, euphoria, vomiting, and increased osmolal gap
      • Methanol ingestion may produce an odor on breath that is similar to that of ethanol but fainter (unreliable sign)
      • Characteristically toxicity results in prominent, latent (after 6-30 hours) ocular symptoms including visual impairment, altered color perception, snowfield vision, and possibly blindness r17
      • Diagnosis is typically based on a high index of suspicion with proper interpretation of adjunct laboratory diagnostics (eg, presentation consistent with alcohol intoxication, increased osmolal gap, severe increased anion gap metabolic acidosis, prominent ocular findings, absence of detectable serum ethanol concentration) and improvement with proper treatment (eg, antidote fomepizole)
      • Serum methanol concentration confirms diagnosis but is of limited use given need for reference laboratory testing (lengthy turnaround time)
    • Isopropyl alcohol toxicity r24r25c130
      • Isopropyl alcohol (isopropanol) is the common solvent in household rubbing alcohol
      • Initial manifestations can mimic those of ethanol toxicity with inebriation, vomiting, central nervous system depression, and hyperosmolarity (ie, increased osmolal gap); notably, development of acidosis is absent in isolated isopropyl alcohol ingestion
      • Clinical clues to isopropyl alcohol intoxication are fruity breath odor (ketones) with substantial ketonemia and ketonuria without acidemia; elevated blood and urine acetone concentrations (ie, strong positive nitroprusside reaction) without elevation of β-hydroxybutyrate levels is characteristic
      • Very high acetone concentrations can falsely elevate serum creatinine level (whereas BUN level remains within reference range) and result in false-positive ethanol breath test result
      • Serum isopropanol concentration confirms diagnosis but is of limited utility given need for reference laboratory testing (lengthy turnaround time); management parallels that of acute ethanol ingestion
    • Benzodiazepine toxicity c131
      • Presentation is practically identical to that of acute ethanol toxicity (eg, central nervous system depression, slurred speech, ataxia)
      • Distinguishing feature in patients with isolated, acute benzodiazepine toxicity is that smell of ethanol on breath is absent
      • Flumazenil can reverse toxic effects of benzodiazepines
        • Use with caution owing to potential for adverse effects, including:
          • Increased intracranial pressure
          • Ventricular dysrhythmias
          • Seizures in patients with epilepsy or coingestion associated with lowering of seizure threshold
          • Acute benzodiazepine withdrawal
      • Differentiate and diagnose by clinical presentation; detection of benzodiazepine on drug screen provides evidence of recent exposure
    • Opioid toxicity c132d4
      • May present similarly with drowsiness, inebriation, mental status depression, and hypothermia
      • Additional common signs of overdose include miosis, bradycardia, and hypotension
      • Naloxone may reverse manifestations
      • Differentiate and diagnose by clinical presentation and clinical course; detection of opioid on drug screen provides evidence of recent exposure
    • Wernicke-Korsakoff syndrome r6c133
      • Both conditions are a consequence of thiamine (vitamin B₁) deficiency and are diagnosed based on clinical presentation
      • Patients with alcohol use disorder are at increased risk of vitamin B₁ deficiency secondary to poor nutrition, compromised gastrointestinal absorption, reduced B₁ storage, and impaired utilization of B₁
      • Wernicke encephalopathy
        • Acute and reversible consequence of thiamine deficiency
        • May present similarly with acute mental status changes (eg, apathy, inattention, confusion, coma), ataxia, and ocular abnormalities (eg, nystagmus, ophthalmoplegia)
        • Dramatic improvement is often noted with parenteral thiamine replacement
        • Diagnosis is based on clinical criteria (at least 2 of 4 conditions in a person with known long-term ethanol use: nutritional deficiency, ocular findings, ataxia, and/or mental status changes) r8
      • Korsakoff syndrome
        • Untreated Wernicke encephalopathy can progress to Korsakoff syndrome which is characterized by disproportionate impairment in memory relative to other aspects of cognitive functioning
        • May present similarly to ethanol intoxication with amnesia
        • Amnesia associated with Korsakoff syndrome is global and chronic, whereas amnesia (blackout) associated with ethanol intoxication is temporary
        • Diagnosis is clinical
    • Hepatic encephalopathy r6c134
      • Presents with confusion and change in personality mimicking ethanol intoxication
      • Usually precipitated by an event such as gastrointestinal bleed, electrolyte abnormalities, dehydration, infection, excessive use of central nervous system depressant medication, or ethanol intoxication
      • Severe encephalopathy may progress to cerebral edema, increased intracranial pressure, and death
      • Unlike with ethanol intoxication, asterixis is often noted on examination; laboratory tests often find elevated liver enzyme levels and ammonia levels
      • Diagnosis is based on clinical presentation, clinical course, and laboratory values
    • Central nervous system infection c135
      • Meningitis and encephalitis may mimic ethanol intoxication with mental status changes, vomiting, and seizures
      • In contrast with patients with ethanol intoxication, patients with central nervous system infection most often present with fever and meningeal signs
      • Diagnosed with lumbar puncture and cerebrospinal fluid analysis
    • Beer potomania r8c136
      • Condition results from ethanol-induced hyponatremia in malnourished people with long-term ethanol use
      • Presents similarly to ethanol intoxication with altered mental status and seizures
      • Concomitant findings in patients with beer potomania include low potassium levels, euvolemic state (with normal BUN and creatinine levels), low serum osmolality, and low urine sodium level
      • Differentiate from acute intoxication by presence of hyponatremia
      • Diagnosis is confirmed by excluding other causes of hyponatremia in a person with long-term ethanol use

    Treatment

    Goals

    • Provide effective resuscitation when indicated
    • Provide symptomatic care; no antidote is available for ethanol intoxication; replace thiamine when indicated
    • Treat concomitant conditions such as hypoglycemia, dehydration, vomiting, electrolyte abnormalities (eg, hyponatremia, hypomagnesemia), seizures, and agitation

    Disposition

    Admission criteria

    Admit children with acute ethanol toxicity for close monitoring for hypoglycemia and further management

    Indications for admission of adults r16

    • Persistently abnormal vital signs (eg, hypotension)
    • Persistently abnormal mental status with or without an identifiable cause
    • Respiratory depression
    • Overdose with intended self-harm
    • Concomitant serious trauma
    • Consequential ethanol withdrawal
    • Associated serious disease process (eg, gastrointestinal bleed, pancreatitis)
    • Complication requiring ongoing management (eg, dehydration, hypoglycemia)
    Criteria for ICU admission
    • Respiratory failure, severe withdrawal, and some concomitant conditions (eg, sepsis, intracranial hemorrhage) require ICU level of care r26
      • Risk factors for ICU requirement include hypoglycemia, fever, hypothermia, hypoxia, hypotension, sedation requirement, and tachycardia

    Recommendations for specialist referral

    • Consult poison control center and/or medical toxicologist for management concerns
    • Consult substance use/addiction medicine specialist or mental health provider for diagnostic and treatment recommendations regarding concerns about alcohol use disorder

    Treatment Options

    Treatment is multifaceted, addressing several medical issues

    Resuscitation

    • Protect airway; provide respiratory and cardiovascular support per standard protocols

    Dehydration and hypovolemia

    • Treat with IV fluid bolus and ongoing infusion
    • Consider IV solution with dextrose, magnesium, folate, thiamine, and multivitamins per institutional protocol when IV fluids are required r3
    • IV fluid administration does not alter blood ethanol clearance r2

    Metabolic abnormalities

    • Thiamine deficiency
      • Consider thiamine replacement in patients at risk for deficiency: those with malnutrition, long-term ethanol use, alcohol use disorder, or (in adults) hypoglycemia r7
    • Hypoglycemia
      • Treat with oral glucose if possible; IV dextrose bolus followed by infusion and close monitoring of serum glucose levels may be required
      • Replace thiamine (B₁) in older patients (probably not necessary in children) or malnourished patients when bolusing with glucose; give thiamine dose via parenteral route r8
      • Note that hypoglycemia is usually unresponsive to glucagon r7
    • Electrolyte abnormalities
      • Correct in standard way per institutional protocol
      • Do not correct hyponatremia too rapidly, given increased risk for osmotic demyelination syndrome (ie, central pontine and extrapontine myelinolysis) in patients with alcohol use disorder d5

    Neurologic abnormalities

    • Seizures
      • Treat hypoglycemia when present
      • Treat per standard protocol beginning with benzodiazepine (eg, lorazepam) administration
    • Agitation and restlessness
      • Avoid use of physical restraints owing to risk of traumatic injury and rhabdomyolysis in acutely agitated patients r3
        • Temporary use may be necessary when condition is extreme
      • First line pharmacotherapy is typical antipsychotics (eg, haloperidol);r5r3ketamine may be an alternativer27r28
      • Maintain caution with any medication with potential to cause respiratory depression (eg, benzodiazepines) r16

    Other symptomatic care

    • Vomiting
      • Place patient in lateral position and provide gentle suction as needed to clear oropharynx and lower risk of aspiration r6
      • Consider antiemetic administration (eg, ondansetron) when contraindications are absent r6
    • Hypothermia
      • Treat in standard fashion with external warming measures (eg, warm blankets, external warming system, radiant heat, heat lamps)

    Hemodialysis

    • May be considered in the following urgent circumstances: r7
      • Ethanol concentration more than 750 mg/dL
      • Severe metabolic acidosis
      • Severely impaired liver function

    Drug therapy

    • Thiamine c137d6
      • Several dosing regimens are available
      • Give thiamine before any glucose administration to avoid precipitating Wernicke encephalopathy r29
      • To prevent Wernicke encephalopathy:
        • Oral
          • Vitamin B₁ (Thiamine) Oral tablet; Adults: 100 mg PO once daily for 3 to 5 days. r30
        • IV
          • Vitamin B₁ (Thiamine Hydrochloride) Solution for injection; Adults: 100 mg IV once daily for 3 to 5 days. r31
      • To treat Wernicke encephalopathy based on suggestive symptoms:
        • Vitamin B₁ (Thiamine Hydrochloride) Solution for injection; Adults: 500 mg IV every 8 hours for 5 days, followed by 250 mg IV once daily for 3 to 5 days depending on response. r31
    • IV solution with dextrose, magnesium, folate, thiamine, and multivitamins c138
      • Premixed IV solution of 1:1 5% dextrose and 0.45% sodium chloride, 2 gm of magnesium sulfate, 1 mg of folate, 100 mg of thiamine, and multivitamins. r3
    • Haloperidol c139
      • May be used to diminish agitation in violent or agitated patients r3
      • Maintain caution because interactions between medications with sedative properties and ethanol may precipitate respiratory depression and hypotension r3
      • Haloperidol Lactate Solution for injection; Adults: 2 to 10 mg IM every 20 to 30 minutes as needed. Max: 20 mg/day.
    • Dextrose infusion
      • Dextrose 10% Solution for Injection; Neonates, Infants, and Children: 2 to 3 mL/kg bolus, followed by continuous infusion rate beginning at 4 to 8 mg/kg/minute.
      • Dextrose Solution for injection; Adults: 10 to 25 g/dose IV as a single dose. In severe cases, repeat doses may be needed. Subsequent continuous IV infusion may be necessary to stabilize serum glucose concentrations in some individuals.
    • Other glucose supplementation c140
      • Glucose oral tablets; Children: 0.3 g glucose per kg body weight (5 to 20 g depending on the child's body weight).

    Nondrug and supportive care

    • Psychiatric evaluation c141
      • Indicated for all patients intending self-harm
    • Social service evaluation c142
      • Recommended for all children presenting with acute intoxication to ensure safety of living environment and to assess competency of caregiver
    • Screen for heavy long-term ethanol use and alcohol use disorder before discharge c143d1
    • Evaluate for risk of alcohol withdrawal before discharge; provide referrals for medication-assisted treatment as indicated c144d6

    Comorbidities

    • Alcohol use disorder c145
      • Patients are at heightened risk for vitamin deficiencies and withdrawal when presenting with acute ethanol intoxication
        • Maintain low threshold for thiamine replacement and folate supplementation d6
        • Assess risk for withdrawal and recommend close follow-up to assess need for medically assisted withdrawal treatment d6
      • Brief intervention after clearing of sensorium is the first step to define and formulate treatment plan for alcohol use disorder; refer for appropriate intensive pharmacologic, psychiatric, and psychosocial treatment of alcohol use disorder d1

    Special populations

    • Children
      • More susceptible to hypoglycemia than other age groups; young children are particularly vulnerable to hypoglycemia even when not much ethanol was ingested
      • Heightened monitoring and more aggressive treatment of hypoglycemia may be warranted

    Monitoring

    • Monitoring for symptomatic patients
      • Repeat clinical assessments of mental status and neurologic examination frequently r6
      • Mental status c146c147
        • Acute manifestations of ethanol intoxication (eg, slurred speech, altered mental status, ataxia) can mask or mimic comorbid conditions; improvement in manifestations (eg, better mental status, cessation of vomiting) is expected after acute intoxication
        • Failure of mental status to improve and persistent vomiting raise suspicion for occult traumatic central nervous system injury or additional comorbid medical condition; further investigation may be indicated
      • Hypoglycemia
        • It is typical to monitor blood glucose levels at least hourly in adult patients with hypoglycemia and to adjust glucose infusion rate accordingly r7c148
        • Children in particular require close monitoring for hypoglycemia
          • A reasonable monitoring schedule is to check blood glucose level hourly until stable, and then every 4 hours for a total of at least 24 hours c149c150
      • Monitoring of abnormal laboratory findings
        • Follow up on electrolyte abnormalities requiring treatment with repeated laboratory tests as appropriate
          • Choose frequency of monitoring based on severity of abnormality, age of patient, and clinical course
    • Discharge criteria
      • Reassess and reexamine for possibility of occult trauma, including brain trauma and cervical spine injury, before discharge when sensorium is clear
      • Screen for heavy long-term ethanol use and alcohol use disorder before discharge; use a validated screener such as the AUDIT-C short questionnaire (Alcohol Use Disorders Identification Test–Consumption) or the CAGE questionnaire (cut down, annoyed, guilty, eye opener) r3c151c152d1
        • If screening result is positive then administer a second tier screening tool such as the full AUDIT questionnaire and assess for DSM-5 alcohol use disorder criteria; perform brief behavioral intervention and refer patients with suspected alcohol use disorder for formal, structured treatment
        • If screening result is negative and alcohol use disorder is not suspected then perform brief alcohol counseling intervention with the goal of reducing harm by reducing harmful drinking practices
      • Generally accepted discharge criteria include ability to walk without difficulty, tolerate oral intake, and demonstrate clear and appropriate thought process in patients who are not a danger to themselves or others r2
        • Ideally patients are discharged to a protected environment under the supervision of another sober and competent adult r16
    • Monitoring of asymptomatic children after ingestion
      • Monitor for development of clinical manifestations for 2 to 4 hours after ingestion, in consultation with poison control center or medical toxicologist c153
      • Confirm maintenance of euglycemia with repeated serum glucose measurement before discharge c154

    Complications and Prognosis

    Complications

    • Dehydration c155
      • May occur secondary to gastrointestinal losses, ethanol-related diuresis, and diminished intake
    • Electrolyte disorders
      • Hyponatremia c156d5
        • May occur in association with acute intoxication, particularly in people with long-term ethanol use r8
        • Causes are diverse and may include hypovolemia, beer potomania, pseudohyponatremia (hypertriglyceridemia, hyperproteinemia), syndrome of inappropriate antidiuretic hormone, cardiomyopathy, cirrhosis, and cerebral salt-wasting syndrome r8
      • Hypomagnesemia c157d7
        • Present in up to 7% of acutely intoxicated patients and up to 30% with alcohol use disorder r8
        • Causes in people with long-term ethanol use are diverse; they include dietary deficiency, malabsorption, increased urinary excretion, ketosis, and vitamin D deficiency r8
    • Hypoglycemia c158c159
      • Children are at highest risk regardless of nutritional status; derangement may occur several hours after ethanol ingestion
      • Much less common in adults; malnutrition and fasting state place adults at higher risk
      • Development does not appear to be related to dose of ethanol or blood ethanol concentration
    • Alcoholic ketoacidosis r8c160
      • Patients with alcoholic ketoacidosis generally present with the triad of abdominal pain, nausea, and vomiting
        • Typical scenario is a recent alcoholic binge causing abdominal pain, which causes cessation of drinking, subsequently leading to the alcoholic acidosis, which causes nausea and vomiting
      • Laboratory findings include elevated anion gap acidosis, ketonuria, and occasionally ketoacidemia
        • β-hydroxybutyrate is present in much higher concentrations than in diabetic ketoacidosis
      • Treat with isotonic volume expansion with dextrose-containing fluids, such as 5% dextrose in normal saline
    • Pulmonary complications
      • Aspiration c161
        • May occur secondary to decreased airway sensitivity to foreign bodies, impaired mucociliary clearance, respiratory depression, and diminished gag reflex r3
        • Aspiration may be associated with increased risk for respiratory infection (eg, bronchitis, pneumonia) r3c162c163c164d8
    • Gastrointestinal complications
      • Mallory-Weiss tear c165
        • Presents with hematemesis secondary to longitudinal laceration at the gastroesophageal junction; may occur with forceful retching or vomiting r6
      • Esophagitis, gastritis, and gastric ulcers c166c167c168
        • Secondary to direct mucosal irritation caused by ethanol r6
      • Pancreatitis c169
        • Secondary to inflammation of pancreas caused by heavy drinking r6
      • Dysfunctional gastrointestinal motility c170
      • Acute alcoholic hepatitis c172d2
        • Acute ethanol intoxication may induce acute hepatitis, particularly in patients with comorbid alcohol use disorder or alcoholic cirrhosis r3
    • Atrial and ventricular arrhythmias c173c174
      • May occur after acute intoxication without underlying comorbid cardiac disease r32
      • May further worsen underlying cardiac impairment or acutely increase risk for lethal arrhythmia in patients with myocardial infarction r32
      • New-onset atrial fibrillation after ethanol consumption (referred to as holiday heart syndrome) is not uncommon r32
    • Sleep abnormalities during episode of intoxication
      • Exacerbation of sleep apnea r6c175
        • Secondary to relaxation of pharyngeal musculature
      • Sleep fragmentation and nonrestorative sleep r6c176c177
    • Peripheral neuropathy c178
      • Patients with long-term ethanol use may experience manifestations of peripheral neuropathy after an intoxicating episode r6
      • Symptoms often include bilateral paresthesias with limb numbness, tingling, and burning sensations; symptoms are usually more pronounced in a distal (rather than proximal) distribution r6
    • Transient hormonal changes associated with acute ethanol intoxication (none require specific medical intervention)
      • Vasopressin secretion inhibition with resultant diuresis r6c179c180
      • Increase in adrenocorticotropic hormone and cortisol levels; decrease in thyroxine and triiodothyronine levels r6c181c182c183c184
    • Risk-taking behavior
      • Can include behaviors that may harm the intoxicated individual or others r33
    • Traumatic injury c185
      • Increased risk of traumatic injury is associated with acute ethanol intoxication r6
      • Clinical course of traumatic injury associated with ethanol use may be worse, with increased risk for intubation, duration of hospitalization, and mortality r3
    • Violent crime c186c187c188c189
      • Binge drinking is associated with increased risk of homicide, assault, robbery, and sexual offenses r4
    • Suicide or suicide attempts c190c191
      • Highly associated with acute ethanol intoxication, particularly in patients with underlying psychiatric comorbidity r4
    • Death c192
      • Lethal dose is variable
        • Death attributable to acute intoxication generally occurs with concentrations exceeding 500 mg/dL r3
        • Death attributable to acute intoxication in nontolerant or ethanol-naive patients may occur at lower concentrations (eg, 300-500 mg/dL) r3
        • Fatal complications may occur at much lower blood ethanol concentrations in children (less than 50 mg/dL) r2
      • Cause of death is usually respiratory arrest with or without aspiration c193

    Prognosis

    • General prognosis of uncomplicated acute ethanol toxicity is favorable with appropriate supportive care r1

    Screening and Prevention

    Prevention

    • Prevent accidental ingestion in children by educating caregivers of risk and making substances inaccessible (eg, ethanol-containing mouthwash, cosmetics, cleaning products, beverages) r5c194
    Wang C et al: Outcomes after toxic alcohol poisoning: a systematic review protocol. Syst Rev. 7(1):250, 201830593287Alcohol, ethanol. In: ToxED [database online]. Elsevier; 2018. Updated August 2018. Accessed September 9, 2021. http://toxed-ip.com/ToxEdView.aspx?id=592345http://toxed-ip.com/ToxEdView.aspx?id=592345Vonghia L et al: Acute alcohol intoxication. Eur J Intern Med. 19(8):561-7, 200819046719American Psychiatric Association: Alcohol intoxication. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013:497-9Pianca TG et al: Identification and initial management of intoxication by alcohol and other drugs in the pediatric emergency room. J Pediatr (Rio J). 93(suppl 1):46-52, 201728886402Jung YC et al: Alcohol: intoxication and poisoning--diagnosis and treatment. Handb Clin Neurol. 125:115-21, 201425307571Vale A: Alcohols and glycols. Medicine. 44(3):128-32, 2016https://doi.org/10.1016/j.mpmed.2015.12.001Allison MG et al: Alcoholic metabolic emergencies. Emerg Med Clin North Am. 32(2):293-301, 201424766933Karimi S et al: Alcohol and the eye. J Ophthalmic Vis Res. 16(2):260-270, 202134055263Rusyn I et al: Alcohol and toxicity. J Hepatol. 59(2):387-8, 201323391479Morton H; for the National Conference of State Legislatures: Powdered Alcohol 2017 Legislation. NCSL website. Updated May 11, 2017. Accessed September 9, 2021. http://www.ncsl.org/research/financial-services-and-commerce/powdered-alcohol-2017-legislation.aspxhttp://www.ncsl.org/research/financial-services-and-commerce/powdered-alcohol-2017-legislation.aspxVanilla Extract and Concentrated Vanilla Extract, 21 CFR §169.175-6 . Updated September 7. 2021. Accessed September 9, 2021https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=7ed0cccd913a2766eedb08d08cfb4ada&mc=true&n=sp21.2.169.b&r=SUBPART&ty=HTML#se21.2.169_1175Tran MN et al: Alcohol dehydrogenase and catalase content in perinatal infant and adult livers: potential influence on neonatal alcohol metabolism. Toxicol Lett. 169(3):245-52, 200717343998Donovan JE: Estimated blood alcohol concentrations for child and adolescent drinking and their implications for screening instruments. Pediatrics. 123(6):e975-81, 200919482748Edmunds SM et al: Acute obtundation in a 9-month-old patient: ethanol ingestion. Pediatr Emerg Care. 30(10):739-41, 201425275356Yip L: Ethanol. In: Hoffman RS et al, eds: Goldfrank's Toxicologic Emergencies. 10th ed. McGraw-Hill Education; 2015:1082-93Kruse JA: Methanol and ethylene glycol intoxication. Crit Care Clin. 28(4):661-711, 201222998995Kraut JA et al: Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 3(1):208-25, 200818045860Charney AN et al: Fluid, electrolyte, and acid-base principles. In: Hoffman RS et al, eds: Goldfrank's Toxicologic Emergencies. 10th ed. McGraw-Hill Education; 2015:248-61Porter WH: Ethylene glycol poisoning: quintessential clinical toxicology; analytical conundrum. Clin Chim Acta. 413(3-4):365-77, 201222085425Gennari FJ: Current concepts. Serum osmolality. Uses and limitations. N Engl J Med. 310(2):102-5, 19846361557Ethylene glycol. In: ToxED [database online]. Elsevier; 2016. Updated January 5 2016. Accessed September 9, 2021 http://toxed-ip.com/ToxEdView.aspx?id=592511http://toxed-ip.com/ToxEdView.aspx?id=592511Methanol, methyl alcohol. In: ToxED [database online]. Elsevier; 2016. Updated July 27, 2020. Accessed September 9, 2021. http://toxed-ip.com/ToxEdView.aspx?id=592428http://toxed-ip.com/ToxEdView.aspx?id=592428Isopropanol, isopropyl alcohol. In: ToxED [database online]. Elsevier; 2015. Updated April 14, 2021. Accessed September 9, 2021. http://toxed-ip.com/ToxEdView.aspx?id=1412880http://toxed-ip.com/ToxEdView.aspx?id=1412880Jammalamadaka D et al: Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 339(3):276-81, 201020090509Klein LR et al: Unsuspected critical illness among emergency department patients presenting for acute alcohol intoxication. Ann Emerg Med. 71(3):279-88, 201828844504Hopper AB et al: Ketamine use for acute agitation in the emergency department. J Emerg Med. 48(6):712-9, 201525843924Isbister GK et al: Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department. Ann Emerg Med. 67(5):581-7.e1, 201626899459Schmidt KJ et al: Treatment of severe alcohol withdrawal. Ann Pharmacother. 50(5):389-401, 201626861990Stephens JR et al: Who needs inpatient detox? Development and implementation of a hospitalist protocol for the evaluation of patients for alcohol detoxification. J Gen Intern Med. 29(4):587-93, 201424395104Long D et al: The emergency medicine management of severe alcohol withdrawal. Am J Emerg Med. 35(7):1005-11, 201728188055Mustroph J et al: Mechanisms of cardiac ethanol toxicity and novel treatment options. Pharmacol Ther. ePub, 201830557629Brooks M et al: A systematic review of event-level measures of risk-taking behaviors and harms during alcohol intoxication. Addict Behav. 99:106101, 201931473569
    Small Elsevier Logo

    Cookies are used by this site. To decline or learn more, visit our cookie notice.


    Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

    Small Elsevier Logo
    RELX Group